Viewing Study NCT05918133


Ignite Creation Date: 2025-12-25 @ 2:58 AM
Ignite Modification Date: 2026-02-25 @ 6:43 PM
Study NCT ID: NCT05918133
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-11
First Post: 2023-06-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
Sponsor: Biotheus Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module